What is Telmisartan-Amlodipine?
Telmisartan-amlodipine combines telmisartan, an angiotensin II receptor blocker, with amlodipine, a calcium channel blocker, in one tablet for high blood pressure. The original brand, Twynsta, is listed as discontinued, and the combination is now supplied as generic tablets. It can be used as a first treatment in people likely to need several drugs, to add to either component alone, or to replace both taken separately. It carries a boxed warning against use in pregnancy.1
Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3
The two drugs lower blood pressure by different routes: telmisartan blocks angiotensin II, while amlodipine relaxes arterial smooth muscle by blocking calcium entry, and their pharmacokinetics are not altered when they are given together.1
Telmisartan side effects are uncommon and independent of dose, whereas amlodipine causes dose-dependent ankle swelling, so lowering the amlodipine share can ease that problem.
The tablets are bilayer: one layer contains amlodipine and the other telmisartan, each with its own colour and code.
Most of the combined effect appears within two weeks, and it was larger than either drug alone at every assessment through eight weeks.1
Response was similar in older and younger patients and in men and women, and approached that in non-Black patients among the limited number of Black participants.1
The combination is one of the blood pressure medicines; amlodipine with olmesartan is a similar pairing.
